|
个人信息Personal Information
硕士生导师
教师拼音名称:liuxuefei
出生日期:1996-12-16
电子邮箱:
入职时间:2026-09-22
所在单位:生命科学学院
职务:特聘副教授
学历:研究生(博士)毕业
办公地点:湖南省长沙市岳麓区桐梓坡路172号中南大学杏林校区生命科学学院大楼D407
性别:男
联系方式:liuxf6@csu.edu.cn 12231372@mail.sustech.edu.cn
学位:理学博士学位
毕业院校:南方科技大学
Liu X.#, Tan J.#, Wu C.#, et al. GPNMB Drives Brain Metastasis by Sculpting a Pathological Endothelial-Immune Interactome. Cancer Discovery. 2026. Apr 15. (共同一作排名第一,IF:29.5)
Liu X.#, Wang C.#, Huang Y.#, et al. Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti-Tumor by Blocking Metabolic Interactions in Organoids.Advanced Science (Weinh). 2024 Nov;11(42):e2406653. (共同一作排名第一, IF:14.1)
Yu M. #, Duan L. #, Huang Y. # ... & Liu X. NMB⁺ CXCL13⁺ CD4⁺ T cell-derived neuromedin-B promotes senescence and stemness of NPSR1⁺ malignant cells. Cancer Immunology Research. 2026 Apr 24. (最后通讯, IF: 7.9)
Liu X.#, Wang Y.#, Cheng Y.#, et al.The Paracrine TAC1-TACR1 Signaling Promotes Endothelial Senescence and Metastatic Progression in Neuroblastoma. Cancer Letters.2026 Jul 10;650:218506. (共同一作排名第一, IF: 11.8)
Li R #, Liu X. #, Huang X. #,et al. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. Gut, 2024 Feb 23;73(3):470-484. (共同一作排名第二, IF: 24.6)
Wu C.#, Liu X.#, *, Gu L.#, et al.The Tumor-to-endothelial Transfer of FTO Promotes Vascular Remodeling and Metastasis in Nasopharyngeal Carcinoma. Advanced Science (Weinh). 2026 Feb;13(8):e09524. (共同一作排名第二,共同通讯, IF: 14.1)
Wu C.#, Liu X.#, Zhao B.#, et al.CBX3 confers ferroptosis resistance during blood-borne metastasis. Journal of Hematology & Oncology. 2026. Jan 15;19(1):9. (共同一作排名第二, IF: 47.8)
Xu K#,Liu X#, Zeng Q#, et al.Cannabinoid CB2 receptor controls chronic itch by regulating spinal microglial activation and synaptic transmission. Cell Reports.2025 Apr 22;44(4):115559. (共同一作排名第二, IF: 7.7)
Cheng Y#, Huang G#,Liu X#, et al. Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer. Cancer Research. 2025 Dec 4:OF1-OF18 (共同一作排名第三, IF: 22.6)

